As of Sep 30
| +0.12 / +3.75%|
The 1 analysts offering 12-month price forecasts for Orexigen Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +50.60% increase from the last price of 3.32.
The current consensus among 4 polled investment analysts is to Hold stock in Orexigen Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.